-
Loading metrics
Early detection of venous thromboembolism after the initiation of chemotherapy predicts a poor prognosis in patients with unresectable metastatic pancreatic cancer who underwent first-line chemotherapy with gemcitabine plus nab-paclitaxel
-
Takuo Yamai,
Roles Conceptualization, Writing – original draft
Affiliation Department of Hepatobiliary and Pancreatic Oncology, Osaka International Cancer Institute, Osaka, Japan
⨯ -
Kenji Ikezawa ,
Roles Writing – review & editing
* E-mail: ikezawa-ke@oici.jp
Affiliation Department of Hepatobiliary and Pancreatic Oncology, Osaka International Cancer Institute, Osaka, Japan
⨯ - Erika Hiraga,
- Yasuharu Kawamoto,
- Takeru Hirao,
- Sena Higashi,
- Kazuma Daiku,
- Shingo Maeda,
- Yutaro Abe,
- Makiko Urabe,
- Yugo Kai,
- Ryoji Takada,
-
Tasuku Nakabori,
Roles Writing – review & editing
Affiliation Department of Hepatobiliary and Pancreatic Oncology, Osaka International Cancer Institute, Osaka, Japan
⨯ - Nobuyasu Fukutake,
- Hiroyuki Uehara,
-
Masashi Fujita,
Roles Supervision
Affiliation Department of Onco-Cardiology, Osaka International Cancer Institute, Osaka, Japan
⨯ - [ ... ],
- Kazuyoshi Ohkawa
- [ view all ]
- [ view less ]
https://orcid.org/0000-0002-5448-4763
Early detection of venous thromboembolism after the initiation of chemotherapy predicts a poor prognosis in patients with unresectable metastatic pancreatic cancer who underwent first-line chemotherapy with gemcitabine plus nab-paclitaxel
- Takuo Yamai,
- Kenji Ikezawa,
- Erika Hiraga,
- Yasuharu Kawamoto,
- Takeru Hirao,
- Sena Higashi,
- Kazuma Daiku,
- Shingo Maeda,
- Yutaro Abe,
- Makiko Urabe
x
- Published: March 1, 2022
- https://doi.org/10.1371/journal.pone.0264653